Patents by Inventor Christophoros Christou Vassiliou

Christophoros Christou Vassiliou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Implantable Dissolved Oxygen Sensor and Methods of Use
    Publication number: 20210030321
    Abstract: A sensor is provided for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site and in ex vivo applications. The sensor includes an article comprising a sensing medium retained within the implantable article by an oxygen-permeable material. The sensing medium comprises an MR contrast agent for oxygen. The sensor is configured to indicate the dissolved oxygen concentration of a fluid, e.g., in vivo at the tissue site, when subjected to an MR-based method.
    Type: Application
    Filed: October 7, 2020
    Publication date: February 4, 2021
    Inventors: Vincent Hok Liu, Christophoros Christou Vassiliou, Yibo Ling, Michael J. Cima
  • Implantable dissolved oxygen sensor and methods of use
    Patent number: 10806383
    Abstract: A sensor is provided for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site and in ex vivo applications. The sensor includes an article comprising a sensing medium retained within the implantable article by an oxygen-permeable material. The sensing medium comprises an MR contrast agent for oxygen. The sensor is configured to indicate the dissolved oxygen concentration of a fluid, e.g., in vivo at the tissue site, when subjected to an MR-based method.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: October 20, 2020
    Assignee: Massachusetts Institute of Technology
    Inventors: Vincent Hok Liu, Christophoros Christou Vassiliou, Yibo Ling, Michael J. Cima
  • Implantable Dissolved Oxygen Sensor and Methods of Use
    Publication number: 20130046164
    Abstract: A sensor is provided for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site and in ex vivo applications. The sensor includes an article comprising a sensing medium retained within the implantable article by an oxygen-permeable material. The sensing medium comprises an MR contrast agent for oxygen. The sensor is configured to indicate the dissolved oxygen concentration of a fluid, e.g., in vivo at the tissue site, when subjected to an MR-based method.
    Type: Application
    Filed: May 4, 2011
    Publication date: February 21, 2013
    Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Vincent Hok Liu, Christophoros Christou Vassiliou, Yibo Ling, Michael J. Cima